These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells. Lee WJ; Chen WK; Wang CJ; Lin WL; Tseng TH Toxicol Appl Pharmacol; 2008 Jan; 226(2):178-91. PubMed ID: 17961621 [TBL] [Abstract][Full Text] [Related]
9. Role of PI3K and AKT specific isoforms in ovarian cancer cell migration, invasion and proliferation through the p70S6K1 pathway. Meng Q; Xia C; Fang J; Rojanasakul Y; Jiang BH Cell Signal; 2006 Dec; 18(12):2262-71. PubMed ID: 16839745 [TBL] [Abstract][Full Text] [Related]
10. KLF9, a transcription factor induced in flutamide-caused cell apoptosis, inhibits AKT activation and suppresses tumor growth of prostate cancer cells. Shen P; Sun J; Xu G; Zhang L; Yang Z; Xia S; Wang Y; Liu Y; Shi G Prostate; 2014 Jun; 74(9):946-58. PubMed ID: 24737412 [TBL] [Abstract][Full Text] [Related]
11. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells. Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546 [TBL] [Abstract][Full Text] [Related]
12. microRNA-133a regulates the cell cycle and proliferation of breast cancer cells by targeting epidermal growth factor receptor through the EGFR/Akt signaling pathway. Cui W; Zhang S; Shan C; Zhou L; Zhou Z FEBS J; 2013 Aug; 280(16):3962-74. PubMed ID: 23786162 [TBL] [Abstract][Full Text] [Related]
13. FAK activity protects nucleostemin in facilitating breast cancer spheroid and tumor growth. Tancioni I; Miller NL; Uryu S; Lawson C; Jean C; Chen XL; Kleinschmidt EG; Schlaepfer DD Breast Cancer Res; 2015 Mar; 17():47. PubMed ID: 25880415 [TBL] [Abstract][Full Text] [Related]
14. Theaflavins target Fas/caspase-8 and Akt/pBad pathways to induce apoptosis in p53-mutated human breast cancer cells. Lahiry L; Saha B; Chakraborty J; Adhikary A; Mohanty S; Hossain DM; Banerjee S; Das K; Sa G; Das T Carcinogenesis; 2010 Feb; 31(2):259-68. PubMed ID: 19969555 [TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-β1 induces EMT by the transactivation of epidermal growth factor signaling through HA/CD44 in lung and breast cancer cells. Li L; Qi L; Liang Z; Song W; Liu Y; Wang Y; Sun B; Zhang B; Cao W Int J Mol Med; 2015 Jul; 36(1):113-22. PubMed ID: 26005723 [TBL] [Abstract][Full Text] [Related]
16. DNA damage-induced protein 14-3-3 sigma inhibits protein kinase B/Akt activation and suppresses Akt-activated cancer. Yang H; Wen YY; Zhao R; Lin YL; Fournier K; Yang HY; Qiu Y; Diaz J; Laronga C; Lee MH Cancer Res; 2006 Mar; 66(6):3096-105. PubMed ID: 16540659 [TBL] [Abstract][Full Text] [Related]
17. Akt-Girdin signaling in cancer-associated fibroblasts contributes to tumor progression. Yamamura Y; Asai N; Enomoto A; Kato T; Mii S; Kondo Y; Ushida K; Niimi K; Tsunoda N; Nagino M; Ichihara S; Furukawa K; Maeda K; Murohara T; Takahashi M Cancer Res; 2015 Mar; 75(5):813-23. PubMed ID: 25732845 [TBL] [Abstract][Full Text] [Related]
18. Lack of HIN-1 methylation in BRCA1-linked and "BRCA1-like" breast tumors. Krop I; Maguire P; Lahti-Domenici J; Lodeiro G; Richardson A; Johannsdottir HK; Nevanlinna H; Borg A; Gelman R; Barkardottir RB; Lindblom A; Polyak K Cancer Res; 2003 May; 63(9):2024-7. PubMed ID: 12727813 [TBL] [Abstract][Full Text] [Related]
20. Formononetin inhibits migration and invasion of MDA-MB-231 and 4T1 breast cancer cells by suppressing MMP-2 and MMP-9 through PI3K/AKT signaling pathways. Zhou R; Xu L; Ye M; Liao M; Du H; Chen H Horm Metab Res; 2014 Oct; 46(11):753-60. PubMed ID: 24977660 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]